Browsing: Iberdomide

In a conversation with CancerNetwork®, Sagar Lonial, MD, FACP, FASCO, discussed the potential implications of the FDA approving iberdomide plus…

The approval of iberdomide might expand the “tool belt” of novel drugs and combination approaches that may help advance towards…

In February 2026, the FDA accepted a new drug application (NDA) seeking approval for iberdomide, a cereblon E3 ligase modulator…

The FDA has accepted a new drug application (NDA) seeking approval for iberdomide plus daratumumab (Darzalex) and dexamethasone as a…